{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:25:36Z","timestamp":1790702736653,"version":"4.1.0"},"reference-count":51,"publisher":"Japan Atherosclerosis Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.5551\/jat.51144","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T22:06:18Z","timestamp":1584137178000},"page":"1039-1052","source":"Crossref","is-referenced-by-count":17,"title":["Myostatin in the Arterial Wall of Patients with End-Stage Renal Disease"],"prefix":"10.5551","volume":"27","author":[{"given":"Pasquale","family":"Esposito","sequence":"first","affiliation":[{"name":"Department of Nephrology, Dialysis and Transplantation, Fondazione IRCCS Policlinico San Matteo, and University of Pavia"},{"name":"Department of Internal Medicine, Nephrology, Dialysis and Transplantation Clinics, Genoa University and IRCCS Ospedale Policlinico San Martino"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Verzola","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology, Dialysis and Transplantation Clinics, Genoa University and IRCCS Ospedale Policlinico San Martino"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo La","family":"Porta","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Transplantation, Fondazione IRCCS Policlinico San Matteo, and University of Pavia"},{"name":"Department of Internal Medicine, Nephrology, Dialysis and Transplantation Clinics, Genoa University and IRCCS Ospedale Policlinico San Martino"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Milanesi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology, Dialysis and Transplantation Clinics, Genoa University and IRCCS Ospedale Policlinico San Martino"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Grignano","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Transplantation, Fondazione IRCCS Policlinico San Matteo, and University of Pavia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Avella","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Transplantation, Fondazione IRCCS Policlinico San Matteo, and University of Pavia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena","family":"Gregorini","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Transplantation, Fondazione IRCCS Policlinico San Matteo, and University of Pavia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Abelli","sequence":"additional","affiliation":[{"name":"Service of Surgery, University of Pavia, Fondazione IRCCS Policlinico San Matteo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ticozzelli","sequence":"additional","affiliation":[{"name":"Service of Surgery, University of Pavia, Fondazione IRCCS Policlinico San Matteo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Rampino","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Transplantation, Fondazione IRCCS Policlinico San Matteo, and University of Pavia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Garibotto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology, Dialysis and Transplantation Clinics, Genoa University and IRCCS Ospedale Policlinico San Martino"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis, 2003; 41: 11-17","DOI":"10.1016\/S0272-6386(03)00372-X"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kooman JP, van der Sande FM, Leunissen KM. Kidney disease and aging: A reciprocal relation. Exp Gerontol, 2017; 87: 156-159","DOI":"10.1016\/j.exger.2016.02.003"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Quek KJ, Boyd R, Ameer OZ, Zangerl B, Butlin M, Murphy TV, Avolio AP, Phillips JK. Progressive vascular remodelling, endothelial dysfunction and stiffness in mesenteric resistance arteries in a rodent model of chronic kidney disease. Vascul Pharmacol, 2016; 81: 42-52","DOI":"10.1016\/j.vph.2015.12.004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, Mall G, Amann K. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant, 2000; 15: 218-223","DOI":"10.1093\/ndt\/15.2.218"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) London GM. Arterial Stiffness in Chronic Kidney Disease and End-Stage Renal Disease. Blood Purif, 2018; 45: 154-158","DOI":"10.1159\/000485146"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circulation research, 2016; 118: 692-702","DOI":"10.1161\/CIRCRESAHA.115.306361"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Ann Rev Physiol, 2012; 74: 13-40","DOI":"10.1146\/annurev-physiol-012110-142315"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ackers-Johnson M, Talasila A, Sage AP, Long X, Bot I, Morrell NW, Bennett MR, Miano JM, Sinha S. Myocardin regulates vascular smooth muscle cell inflammatory activation and disease. Arterioscler Thromb Vasc Biol, 2015; 35: 817-828","DOI":"10.1161\/ATVBAHA.114.305218"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Shanahan CM. Mechanisms of vascular calcification in CKD-evidence for premature ageing? Nat Rev Nephrol, 2013; 9: 661-670","DOI":"10.1038\/nrneph.2013.176"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Briet M, Burns KD. Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications. Clin Sci (Lond), 2012; 123: 399-416","DOI":"10.1042\/CS20120074"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol, 2008; 19: 213-216","DOI":"10.1681\/ASN.2007080854"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Dalfino G, Simone S, Porreca S, Cosola C, Balestra C, Manno C, Schena FP, Grandaliano G, Pertosa G. Bone morphogenetic protein-2 may represent the molecular link between oxidative stress and vascular stiffness in chronic kidney disease. Atherosclerosis, 2010; 211: 418-423","DOI":"10.1016\/j.atherosclerosis.2010.04.023"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K, Ezzat S, Shen R, Lalani R, Asa S, Mamita M, Nair G, Arver S, Bhasin S. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A, 1998; 95: 14938-14943","DOI":"10.1073\/pnas.95.25.14938"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ, Attisano L. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol, 2003; 23: 7230-7242","DOI":"10.1128\/MCB.23.20.7230-7242.2003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Wang DT, Yang YJ, Huang RH, Zhang ZH, Lin X. Myostatin Activates the Ubiquitin-Proteasome and Autophagy-Lysosome Systems Contributing to Muscle Wasting in Chronic Kidney Disease. Oxid Med Cell Longev, 2015; 2015: 684965","DOI":"10.1155\/2015\/684965"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Gruson D, Ahn SA, Ketelslegers JM, Rousseau MF. Increased plasma myostatin in heart failure. Eur J Heart Fail, 2011; 13: 734-736","DOI":"10.1093\/eurjhf\/hfr024"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Gao F, Kishida T, Ejima A, Gojo S, Mazda O. Myostatin acts as an autocrine\/paracrine negative regulator in myo blast differentiation from human induced pluripotent stem cells. Biochem Biophys Res Commun, 2013; 431: 309-314","DOI":"10.1016\/j.bbrc.2012.12.105"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Verzola D, Milanesi S, Bertolotto M, Garibaldi S, Villaggio B, Brunelli C, Balbi M, Ameri P, Montecucco F, Palombo D, Ghigliotti G, Garibotto G, Lindeman JH, Barisione C. Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment. Sci Rep, 2017; 7: 46362","DOI":"10.1038\/srep46362"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Verzola D, Procopio V, Sofia A, Villaggio B, Tarroni A, Bonanni A, Mannucci I, De Cian F, Gianetta E, Saffioti S, Garibotto G. Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease. Kidney Int, 2011; 79: 773-782","DOI":"10.1038\/ki.2010.494"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Zhang L, Pan J, Dong Y, Tweardy DJ, Dong Y, Garibotto G, Mitch WE. Stat3 activation links a C\/EBP\u03b4 to myostatin pathway to stimulate loss of muscle mass. Cell Metab, 2013; 18: 368-379","DOI":"10.1016\/j.cmet.2013.07.012"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Esposito P, La Porta E, Calatroni M, Grignano MA, Milanesi S, Verzola D, Battaglia Y, Gregorini M, Libetta C, Garibotto G, Rampino T. Modulation of Myostatin\/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities. Biomed Res Int, 2017; 2017: 7635459","DOI":"10.1155\/2017\/7635459"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Dong J, Dong Y, Chen Z, Mitch WE, Zhang L. The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro\/adipogenic progenitor cells in chronic kidney disease. Kidney Int, 2017; 91: 119-128","DOI":"10.1016\/j.kint.2016.07.029"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Williams MJ, Sugatani T, Agapova OA, Fang Y, Gaut JP, Faugere MC, Malluche HH, Hruska KA. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. Kidney Int, 2018; 93: 147-158","DOI":"10.1016\/j.kint.2017.06.016"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Esposito P, Rampino T, Gregorini M, Gabanti E, Bianzina S, Dal Canton A. Mechanisms underlying sCD40 production in hemodialysis patients. Cell Immunol, 2012; 278: 10-15","DOI":"10.1016\/j.cellimm.2012.06.007"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Verzola D, Cappuccino L, D'Amato E, Villaggio B, Gianiorio F, Mij M, Simonato A, Viazzi F, Salvidio G, Garibotto G. Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria. Kidney Int, 2014; 86: 1229-1243","DOI":"10.1038\/ki.2014.116"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Junqueira LCU, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J, 1979; 11: 447-455","DOI":"10.1007\/BF01002772"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Churchman AT, Siow RC. Isolation, culture and characterization of vascular smooth muscle cells. Methods Mol Biol, 2009; 467: 127-138","DOI":"10.1007\/978-1-59745-241-0_7"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Verzola D, Bonanni A, Sofia A, Montecucco F, D'Amato E, Cademartori V, Parodi EL, Viazzi F, Venturelli C, Brunori G, Garibotto G. Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease. J Cachexia Sarcopenia Muscle, 2017; 8: 131-144","DOI":"10.1002\/jcsm.12129"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Wang XH, Mitch WE. Mechanisms of muscle wasting in chronic kidney disease. Nature reviews Nephrology, 2014; 10(9): 504-516","DOI":"10.1038\/nrneph.2014.112"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Song Y, Shen H, Schenten D, Shan P, Lee PJ, Goldstein DR. Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 2012; 32: 103-109","DOI":"10.1161\/ATVBAHA.111.236349"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Silva KA, Dong J, Dong Y, Dong Y, Schor N, Tweardy DJ, Zhang L, Mitch WE. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia. J Biol Chem, 2015; 290: 11177-11187","DOI":"10.1074\/jbc.M115.641514"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB Journal, 2004; 18: 39-51","DOI":"10.1096\/fj.03-0610com"},{"key":"33","unstructured":"33) Li HH, Willis MS, Lockyer P, Miller N, McDonough H, Glass DJ, Patterson C. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. J Clin Invest, 2007; 114: 3211-3223"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Willis MS, Schisler JC, Li L, Rodr\u00edguez JE, Hilliard EG, Charles PC, Patterson C. Cardiac muscle ring finger-1 increases susceptibility to heart failure in vivo. Circulation Research, 2009; 105: 80-88","DOI":"10.1161\/CIRCRESAHA.109.194928"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Zhang YQ, Feng B, Yuan FH. Effect of chronic renal failure medium on the ubiquitin-proteasome pathway of arterial muscle cells. Mol Med Rep, 2013; 7: 1021-1025","DOI":"10.3892\/mmr.2013.1269"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Scholze A, Krueger K, Diedrich M, R\u00e4th C, Torges A, Jankowski V, Maier A, Thilo F, Zidek W, Tepel M. Superoxide dismutase type 1 in monocytes of chronic kidney disease patients. Amino Acids, 2011; 41: 427-438","DOI":"10.1007\/s00726-010-0763-4"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Tan R, Zhang J, Tan X, Zhang X, Yang J, Liu Y. Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation. J Am Soc Nephrol, 2006; 17: 2781-2791","DOI":"10.1681\/ASN.2005101055"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Lee, Y. S., Huynh, T. V., Lee, S. J. Paracrine and endocrine modes of myostatin action. J Appl Physiol (1985), 2016; 120: 592-598","DOI":"10.1152\/japplphysiol.00874.2015"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Gabbiani G, Schmid E, Winter S, Chaponnier C, de Ckhastonay C, Vandekerckhove J, Weber K, Franke WW. Vascular smooth muscle cells differ from other smooth muscle cells: Predominance of vimentin filaments and a specific alpha-type actin. Proc Natl Acad Sci USA, 1981; 78: 298-302","DOI":"10.1073\/pnas.78.1.298"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) H\u00e5versen L, Sundelin JP, Mardinoglu A, Rutberg M, St\u00e5hlman M, Wilhelmsson U, Hult\u00e9n LM, Pekny M, Fogelstrand P, Bentzon JF, Levin M, Bor\u00e9n J. Vimentin deficiency in macrophages induces increased oxidative stress and vascular inflammation but attenuates atherosclerosis in mice. Sci Rep, 2018; 8(1): 16973","DOI":"10.1038\/s41598-018-34659-2"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Ritter CS, Zhang S, Delmez J, Finch JL, Slatopolsky E. Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats. Kidney Int, 2015; 87: 1141-1152","DOI":"10.1038\/ki.2015.22"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Hu MC, Shi M, Zhang J, Qui\u00f1ones H, Griffith C, Kuroo M, Moe OW. Klotho deficiency causes vascular calcifi cation in chronic kidney disease. J Am Soc Nephrol, 2011; 22: 124-136","DOI":"10.1681\/ASN.2009121311"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Lim K, Lu TS, Molostvov G, Lee C, Lam FT, Zehnder D, Hsiao LL. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation, 2012; 125: 2243-2255","DOI":"10.1161\/CIRCULATIONAHA.111.053405"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Lindberg K, Olauson H, Amin R, Ponnusamy A, Goetz R, Taylor RF, Mohammadi M, Canfield A, Kublickiene K, Larsson TE. Arterial klotho expression and FGF23 effects on vascular calcification and function. PLoS One, 2013; 8: e60658","DOI":"10.1371\/journal.pone.0060658"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Yamada S, Giachelli CM. Vascular Calcification in CKD-MBD: Roles for Phosphate, FGF23 and Klotho. Bone, 2017; 100: 87-93","DOI":"10.1016\/j.bone.2016.11.012"},{"key":"46","doi-asserted-by":"crossref","unstructured":"47) Shroff R, Long DA, Shanahan C. Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol, 2013; 24: 179-189","DOI":"10.1681\/ASN.2011121191"},{"key":"47","doi-asserted-by":"crossref","unstructured":"48) Glorieux GL, Dhondt AW, Jacobs P, Van Langeraert J, Lameire NH, De Deyn PP, Vanholder RC. In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection. Kidney Int, 2004; 65: 2184-2192","DOI":"10.1111\/j.1523-1755.2004.00631.x"},{"key":"48","doi-asserted-by":"crossref","unstructured":"49) Hong D, Wu S, Pu L, Wang F, Wang J, Wang Z, Gao H, Zhang Y, Deng F, Li G, He Q, Wang L. Abdominal aortic calcification is not superior over other vascular calcification in predicting mortality in hemodialysis patients: a retrospective observational study. BMC Nephrol, 2013; 14: 120","DOI":"10.1186\/1471-2369-14-120"},{"key":"49","doi-asserted-by":"crossref","unstructured":"50) Han, H. Q., Zhou, X., Mitch, W. E., Goldberg A. L. Myostatin\/activin pathway antagonism: molecular basis and therapeutic potential. Int J Biochem Cell Biol, 2013; 45: 2333-2347","DOI":"10.1016\/j.biocel.2013.05.019"},{"key":"50","doi-asserted-by":"crossref","unstructured":"51) Camporez JP, Petersen MC, Abudukadier A, Moreira GV, Jurczak MJ, Friedman G, Haqq CM, Petersen KF, Shulman GI. Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice. Proc Natl Acad Sci USA, 2016; 113: 2212-2217","DOI":"10.1073\/pnas.1525795113"},{"key":"51","doi-asserted-by":"crossref","unstructured":"52) Rentier C, Takayama K, Saitoh M, Nakamura A, Ikeyama H, Taguchi A, Taniguchi A, Hayashi Y. Design and synthesis of potent myostatin inhibitory cyclic peptides. Bioorg Med Chem, 2019; 27: 1437-1443","DOI":"10.1016\/j.bmc.2019.02.019"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/27\/10\/27_51144\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:13:02Z","timestamp":1601694782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/27\/10\/27_51144\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.51144","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}